Why Combine Body Size and Maturation?
A child may have lower clearance than an adult for two distinct reasons: the child has a smaller body size, and clearance pathways may not yet have reached their mature capacity. A size adjustment alone cannot represent developmental change at a fixed weight, while a maturation adjustment alone cannot represent the effect of body size. The purpose of a combined model is to represent both contributions in one equation and make their roles explicit.
This tutorial builds on the introductory material on Maturation Functions for Pediatric Clearance. It treats the chosen allometric exponent and maturation function as specified model components; choosing among candidate exponents or maturation functions is a separate modeling question. The equation is a population prediction model, not a universal law: its suitability depends on the drug, the clearance pathway, and the population to which it is applied.
Deriving the Combined Equation
Suppose clearance scales with weight according to a power relationship. To express this relationship relative to a reference weight, normalize the weight term so that it equals one at \(WT_{\mathrm{ref}}\). The size-scaled clearance is then \(CL_{\mathrm{ref}}(WT_i/WT_{\mathrm{ref}})^b\). The ratio is dimensionless, and the exponent controls how clearance changes with weight under the selected allometric model.
Now let \(M(a_i)\) describe the fraction of mature clearance expected at age \(a_i\), with values between zero and one. Combining the two effects multiplicatively means that the age-related fraction applies to the clearance already scaled for weight. This expresses a specific separability assumption: the relative effect of maturation is represented by the same maturation function across body sizes.
For example, a commonly used sigmoidal maturation function has the form
Here \(TM_{50}\) is the age at which the function reaches one-half, and \(\gamma\) controls its steepness. In this expression, age and \(TM_{50}\) must use the same units, so their powered terms have matching units. The function is zero at age zero when \(\gamma>0\), equals 0.5 at \(a_i=TM_{50}\), and approaches one as age becomes large. This shape is an assumption about the modeled pathway, not evidence that every clearance mechanism matures in this exact way.
Use \((WT_i/WT_{\mathrm{ref}})^b\), which equals one at the reference weight.
Use \(M(a_i)\) to describe the age-related fraction of mature clearance, with a defined age scale and parameters.
Multiply the reference clearance by both dimensionless factors, retaining the clearance units of \(CL_{\mathrm{ref}}\).
The equation follows directly from these definitions. At the reference weight, the size factor is \((WT_{\mathrm{ref}}/WT_{\mathrm{ref}})^b=1\). When maturation is complete, \(M(a_i)\) approaches one. Thus the prediction approaches \(CL_{\mathrm{ref}}\) for an individual at the reference weight with mature clearance. Away from that reference condition, each factor modifies the prediction by its own relative amount.
Worked Predictions
Worked Example: Clearance for a Hypothetical Child
Assume, hypothetically, \(CL_{\mathrm{ref}}=5.00\) L/h at \(WT_{\mathrm{ref}}=70.0\) kg. Use \(b=0.75\). For a child weighing 10.0 kg, suppose the specified maturation function gives \(M(a_i)=0.8000\). Calculate predicted clearance.
First calculate the dimensionless size factor:
Substitute the unrounded size factor and the given maturation fraction:
The predicted clearance is approximately 0.9295 L/h. The maturation factor reduces the size-scaled prediction by 20%, from about 1.1618 L/h to 0.9295 L/h. Rounding an intermediate factor too early can change the final reported value, so the arithmetic uses the unrounded ratio calculation.
Worked Example: Separating Predictions at Two Ages
Keep the hypothetical reference values and \(b=0.75\) from the previous calculation. Consider two hypothetical children, each weighing 10.0 kg. Use \(TM_{50}=0.500\) years and \(\gamma=2\), and evaluate the maturation function at ages 0.250 years and 2.00 years. These ages are used here only as inputs to the specified function.
At 0.250 years:
At 2.00 years:
The size-scaled clearance before applying maturation is \(5.00\times0.232368=1.16184\) L/h for either child. Therefore, the predictions are:
Under this hypothetical model, the older age input produces a larger predicted clearance because the maturation fraction is closer to one. The weight effect is unchanged: both children have the same weight. This comparison isolates the model's age contribution; it does not establish that age alone causes a clearance difference in observed patients.
Worked Example: Changing Weight at the Same Maturity
Use the same hypothetical reference clearance, reference weight, exponent, and maturation fraction of 0.8000. Compare children weighing 10.0 kg and 16.0 kg, holding the age-related maturity fraction fixed. The first child's prediction is 0.92947 L/h before final rounding.
The second child's size factor is:
Thus:
The predicted clearance is approximately 1.322 L/h (or 1.3223 L/h to four significant figures). Because the maturation fractions are equal, the ratio of predictions is determined by the weight ratio alone:
Using the unrounded model calculations, \(1.32229/0.92947\approx1.4226\), as expected. This ratio calculation is a useful consistency check: when age and all other terms are held fixed, the maturation factor and reference clearance cancel.
Assumptions and Checks
Before interpreting a prediction, verify that the model's inputs and structure fit the intended use. The equation relies on the following assumptions:
- Reference consistency: \(CL_{\mathrm{ref}}\) corresponds to the stated \(WT_{\mathrm{ref}}\) and to mature clearance. If the reference value already includes immaturity, applying \(M(a_i)\) may count that effect twice.
- Specified size relationship: the selected exponent and weight measure are appropriate over the range being predicted. The model does not establish that one exponent is suitable for all drugs or ages.
- Separable effects: size and maturation act as multiplicative relative factors. The equation has no extra interaction term allowing the maturation curve itself to vary with weight.
- Appropriate maturation function: the function's age scale, parameter values, and limiting behavior are appropriate for the clearance process and population being modeled.
- Comparable clearance definition: the reference and predicted clearances refer to the same drug, clearance pathway or total clearance measure, and units.
A practical diagnostic is to examine prediction errors or model residuals across both weight and age. Persistent underprediction at one age range and overprediction at another may indicate a misspecified maturation curve or an unsuitable age input. A systematic pattern across weight may suggest that the size relationship is inadequate. These patterns are clues, not definitive diagnoses: data sparsity, measurement error, and other unmodeled covariates can also produce them.
Predictions at the extremes deserve particular caution. A power relationship can yield implausible extrapolations far outside the weights that informed it. Likewise, a maturation function approaching zero near age zero may imply clearance close to zero; whether that is reasonable depends on the drug and the modeled pathway. The combined equation does not itself account for developmental changes in bioavailability, distribution, or other processes that may affect exposure.
Why the Multiplication Matters
The combined model treats each factor as a relative adjustment to the same reference clearance. For instance, if the size factor is 0.2324 and the maturation factor is 0.8000, their combined multiplier is about 0.1859, not their sum. Adding the factors would produce a quantity with no interpretation as a relative clearance multiplier and would fail the reference-condition checks: at reference weight and complete maturity, the intended multiplier is one.
The model also differs from using only one adjustment. A size-only equation predicts the same clearance for two individuals of equal weight, even if their maturation fractions differ. A maturation-only equation predicts the same clearance at a given age regardless of weight. Neither alternative captures both modeled patterns. The combined equation is more expressive, but its extra structure is justified only when supported by pharmacology, data, or an established model.
The equation provides a transparent way to see how size and maturation separately influence predicted clearance, but it does not guarantee accurate predictions. Its use requires a coherent reference, justified component functions, and evaluation over the age and weight range where predictions will be used. The most important interpretation is conditional: predictions change with weight according to the selected power relationship and with age according to the specified maturation function, under the model's assumptions.
Check Your Understanding
Answer each question, then compare your reasoning with the brief solutions.
- If weight equals \(WT_{\mathrm{ref}}\) and \(M(a_i)=1\), what does the model predict?
- For two individuals with equal weight but different maturation fractions, which model component accounts for a difference in predicted clearance?
- At what age does the stated Hill maturation function equal 0.5?
- If the maturation fraction is 0.70, by what factor does it change the size-scaled clearance?
- Name one reason a combined model can still give biased predictions even when the arithmetic is correct.
Solutions. (1) The size factor is one and the maturation factor is one, so \(CL_i=CL_{\mathrm{ref}}\). (2) The maturation factor \(M(a_i)\) differs; the size factor is identical. (3) At \(a_i=TM_{50}\), because the numerator and denominator terms are equal, giving \(M=1/2\). (4) It multiplies the size-scaled clearance by 0.70, reducing that prediction by 30%. (5) Examples include a misspecified allometric relationship, an unsuitable maturation function, an inconsistent reference clearance, or extrapolation beyond the data-supported range.